Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 32

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Evaluation of the Retinal Toxicity of Fludrocortisone Acetate After Intravitreal Injection

M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4281.

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of High–Dose Etanercept

A. Munoz Morales; M. Kivilcim; G.A. Peyman; A.A. Kazi; J.T. Dellacroce; R. Ghabrial

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4293.

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of Infliximab

A.A. Kazi; M. Kivilcim; G.A. Peyman; P. Khan; L. Trost

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4298.

ARVO Annual Meeting Abstract May 2006

Effect of Intravitreally Injected Povidone–Iodine on Staphylococcus epidermidis in Rabbit Eyes

L.W. Trost; M. Kivilcim; G.A. Peyman; A. Munoz Morales

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):5277.

ARVO Annual Meeting Abstract May 2006

Inhibition of Corneal Angiogenesis by Fludrocortisone Acetate and Triamcinolone Acetonide in Rat Model

C.M. Jermak; M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1622.

ARVO Annual Meeting Abstract May 2006

Inhibition of Corneal Neovascularization by Ascorbic Acid in Rat Model

G.A. Peyman; M. Kivilcim; J.T. Dellacroce; A. Munoz Morales

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1634.

ARVO Annual Meeting Abstract May 2006

Inhibition of Experimental Angiogenesis of Cornea by Bevacizumab

M. Ren; R.P. A. Manzano; G.A. Peyman; P. Khan; P. Carvounis; M. Kivilcim

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1638.

ARVO Annual Meeting Abstract May 2006

Inhibition of Experimental Corneal Neovascularization by Diclofenac, Ketorolac, and Etanercept

M.D. Conway; M. Kivilcim; G.A. Peyman; A. Munoz Morales; R.P. A. Manzano

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1639.

ARVO Annual Meeting Abstract May 2006

Intravitreal Toxicity of Rapamycin

R.P. A. Manzano; G.A. Peyman; P. Khan; M. Kivilcim; J. Heffez

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):4248.

ARVO Annual Meeting Abstract May 2005

Predictive Value of Low–Dose Intravitreal Triamcinolone Acetonide for Steroid Responders

M.D. Conway; G.A. Peyman; S. Bhavan; K.A. Khan; M. Khan; R. Varma; S.A. Ebrahim; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):137.

ARVO Annual Meeting Abstract May 2005

The Effect of Combinations of Flurbiprofen, Low Molecular Weight Heparin, and Doxycycline on the Inhibition of Corneal Neovascularization

A.A. Kazi; G.A. Peyman; M.R. Esfahani; E. Aydin; M. Kivilcim; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4478.

ARVO Annual Meeting Abstract May 2005

Combination of Triamcinolone Acetonide With Low Molecular Weight Heparin and Doxycycline in Inhibition of Experimental Corneal Angiogenesis

M. Kivilcim; E. Aydin; G.A. Peyman; M. Riazi Esfahani; A.A. Kazi; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4479.

ARVO Annual Meeting Abstract May 2005

Prevention of Corneal Neovascularization: Evaluation of Various Commercially Available Compounds in an Experimental Rat Model

M. Riazi Esfahani; G.A. Peyman; E. Aydin; A.A. Kazi; D. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4480.

ARVO Annual Meeting Abstract May 2005

Inhibition of Experimental Angiogenesis of Cornea by Doxycycline

E. Aydin; G.A. Peyman; M. Riazi Esfahani; A.A. Kazi; D.R. Sanders

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4481.

ARVO Annual Meeting Abstract May 2005

Buffering Capacity of Bovine Vitreous

C.M. Jermak; M.D. Conway; G.A. Peyman; D.A. Blake

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5386.

ARVO Annual Meeting Abstract May 2005

Intravitreal Toxicity of Doxycycline

G.A. Peyman; E. Aydin; A.A. Kazi; M. Riazi Esfahani

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5560.

ARVO Annual Meeting Abstract May 2005

Intravitreal Toxicity of Garenoxacin

J.T. DellaCroce; M. Riazi Esfahani; A.A. Kazi; G.A. Peyman; E. Aydin

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5561.

ARVO Annual Meeting Abstract May 2005

Intravitreal Toxicity of Povidone–Iodine in Rabbit Eyes

L.W. Trost; M. Kivilcim; G.A. Peyman; E. Aydin; A.A. Kazi

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5566.

ARVO Annual Meeting Abstract May 2005

Intravitreal Toxicity of Moxifloxacin

P.N. S. Khan; E. Aydin; A.A. Kazi; G.A. Peyman; M. Riazi Esfahani

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5574.

ARVO Annual Meeting Abstract May 2004

Intraocular Pressure After Low–Dose 400ug Intravitreal Triamcinolone Acetonide Injection

S. Bhavan; G.A. Peyman; M.D. Conway; I.–S. Kwon

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3945.

1 2

Next 20 Results »

Advertisement